Tengjun Biotechnology Balance Sheet Health
Financial Health criteria checks 6/6
Tengjun Biotechnology has a total shareholder equity of $15.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $439.0M and $423.7M respectively. Tengjun Biotechnology's EBIT is $11.3M making its interest coverage ratio -305.1. It has cash and short-term investments of $25.1M.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | -305.1x |
Cash | US$25.11m |
Equity | US$15.26m |
Total liabilities | US$423.70m |
Total assets | US$438.96m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: TJBH's short term assets ($430.5M) exceed its short term liabilities ($423.7M).
Long Term Liabilities: TJBH has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: TJBH is debt free.
Reducing Debt: TJBH currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Debt Coverage: TJBH has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TJBH has no debt, therefore coverage of interest payments is not a concern.